Lithium and Mental Health: The Small Element with a Big Impact

Lithium has long been established as a first-line mood stabilizer in the treatment of bipolar disorder and treatment-resistant depression.In addition to its psychiatric applications, lithium has demonstrated neuroprotective properties through its influence on neurotransmitter regulation, neuroplasticity, inflammation, and oxidative stress.Objective: This narrative review aims to provide a comprehensive analysis of lithium's role in mental health, focusing on its clinical efficacy, underlying neurobiological mechanisms, and expanding therapeutic applications.The review also addresses safety considerations and explores innovative strategies to optimize lithium use in contemporary psychiatry.Methods: A systematic literature search was conducted in PubMed (MEDLINE) and the Virtual Health Library (BVS), covering publications from January 2000 to December 2024.Inclusion criteria comprised peer-reviewed original studies, systematic reviews, meta-analyses, and randomized clinical trials published in English, Portuguese, or Spanish.A total of 68 articles were selected following title and abstract screening and full-text analysis.These articles explored lithium's clinical effects, mechanisms of action, safety profile, and emerging applications.Results: Lithium remains the gold standard for managing bipolar disorder, with strong evidence supporting its efficacy in mood stabilization and suicide prevention.Emerging data also support its use in major depressive disorder, schizoaffective disorder, and neurodegenerative conditions such as Alzheimer's and Parkinson's disease.However, its narrow therapeutic index necessitates close monitoring due to risks of renal, thyroid, and metabolic dysfunction.Recent advances in pharmacogenomics, sustained-release delivery systems, and microdosing approaches offer new avenues to enhance therapeutic efficacy while reducing adverse effects.Conclusion: Lithium continues to play a pivotal role in psychiatric treatment and is gaining relevance in neuroprotective How to cite this paper:

Authors

Publication Details

Journal
OALib
Published
2025-01-01
DOI
https://doi.org/10.4236/oalib.1113282
Primary Topic
Bipolar Disorder and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lithium and Mental Health: The Small Element with a Big Impact

Fábio Morato de Oliveira, Tamara Rodrigues Lima Zanuzzi, Isabela Dias Cruvinel
OALib
Bipolar Disorder and Treatment
article

Lithium and Mental Health: The Small Element with a Big Impact

Fábio Morato de Oliveira, Tamara Rodrigues Lima Zanuzzi, Isabela Dias Cruvinel
article en

Abstract

Lithium has long been established as a first-line mood stabilizer in the treatment of bipolar disorder and treatment-resistant depression.In addition to its psychiatric applications, lithium has demonstrated neuroprotective properties through its influence on neurotransmitter regulation, neuroplasticity, inflammation, and oxidative stress.Objective: This narrative review aims to provide a comprehensive analysis of lithium's role in mental health, focusing on its clinical efficacy, underlying neurobiological mechanisms, and expanding therapeutic applications.The review also addresses safety considerations and explores innovative strategies to optimize lithium use in contemporary psychiatry.Methods: A systematic literature search was conducted in PubMed (MEDLINE) and the Virtual Health Library (BVS), covering publications from January 2000 to December 2024.Inclusion criteria comprised peer-reviewed original studies, systematic reviews, meta-analyses, and randomized clinical trials published in English, Portuguese, or Spanish.A total of 68 articles were selected following title and abstract screening and full-text analysis.These articles explored lithium's clinical effects, mechanisms of action, safety profile, and emerging applications.Results: Lithium remains the gold standard for managing bipolar disorder, with strong evidence supporting its efficacy in mood stabilization and suicide prevention.Emerging data also support its use in major depressive disorder, schizoaffective disorder, and neurodegenerative conditions such as Alzheimer's and Parkinson's disease.However, its narrow therapeutic index necessitates close monitoring due to risks of renal, thyroid, and metabolic dysfunction.Recent advances in pharmacogenomics, sustained-release delivery systems, and microdosing approaches offer new avenues to enhance therapeutic efficacy while reducing adverse effects.Conclusion: Lithium continues to play a pivotal role in psychiatric treatment and is gaining relevance in neuroprotective How to cite this paper:

OALibVol. 12(04)
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Openalex Percentile: Top 90%
Bipolar Disorder and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.